Skip to main content

Table 2 Differences in BD/DNC guidelines between adults and children

From: Brain death: a clinical overview

 

Infants and children

Adults

Definition

States Uniform Determination of Death Act definition

Uses term “brain death”

Definition of brain death provided

States Uniform Determination of Death Act definition

Uses term “brain death”

Definition of brain death provided

Evidence-based

Yes

Patients who recover function addressed

Yes

Patients who recover function addressed

Qualifications

States examiner must be attending physician competent/qualified to perform brain death evaluation

Specifies a standardized checklist should be used

States that all physicians making a determination of brain death be intimately familiar with brain death criteria and have demonstrated competence in this complex examination

Specifies a standardized checklist should be used

Prerequisites

Establish cause of coma

Establish that brain injury is irreversible

Therapeutic hypothermia discussed—no specific waiting period given

Consider deferring BD evaluation for 24–48 h after resuscitation

When in doubt, observe and postpone BD evaluation

Exclude mimicking conditions

Physiologic parameters normal for age

Metabolic derangements need correction

Neuromuscular blockade addressed (recommends train of four testing if recently given)

Drug intoxication (tables provided for elimination ½ life, says may need to wait several ½ lives)

Temp > 35 °C

Establish cause of coma

Establish that brain injury is irreversible

Therapeutic hypothermia discussed—no specific waiting period given

Ensure certain period of time has passed to exclude the possibility of recovery (usually several hours)

Exclude mimicking conditions

Physiologic parameters normal (SBP ≥ 100)

Metabolic derangements need correction

Neuromuscular blockade addressed (recommends train of four testing if recently given)

Drug intoxication (wait 5 ½ lives)

Temp > 36 °C

Neurologic examination

Number of examinations: 2

(The first examination determines the child has met neurologic examination criteria for brain death. The second examination, confirms that the child has fulfilled criteria for brain death.)

Observation period 12 h (if age > 30 days)

Observation period 24 h (if age 37 weeks estimated gestational age to 30 days)

2 different attending evaluators

Complete neurologic exam: no mention of oculocephalic reflexes, mentions primitive reflexes for neonates/infants

Discusses spinal reflexes

Number of examination: 1

Observation period: none

Complete neurologic exam: OCR and OVR listed, mentions c-spine injury, details on OVR procedure provided

Discusses spinal reflexes

Apnea testing

Mentions prerequisites

2 apnea tests required

Both tests can be done by same attending

Specifies 5–10 min of pre-oxygenation

Specifies high c-spine injury as contraindication

Recommends T-piece or self-inflating bag. Discusses problems with tracheal insufflation using catheter in ETT and problems using CPAP on ventilator

Criteria: no respiratory effort, PaCO2 ≥ 60 and ≥ 20 rise from baseline

Stop apnea test: SaO2 < 85% or hemodynamic instability (no specifics)

Mentions prerequisites, includes no prior evidence of CO2 retention

1 apnea test

Specifies 10 min of pre-oxygenation

Specifies starting PaO2 ≥ 200, drop rate to 10, PEEP to 5

Recommends tracheal insufflation using catheter in ETT

Specifies length of 8–10 min of apnea

Criteria: no respiratory effort, PaCO2 ≥ 60 or ≥ 20 rise from baseline

Stop apnea test: SaO2 < 85% for 30 s, retry with CPAP 10 or SBP < 90

Ancillary testing

Acceptable reasons to use ancillary testing

When components of the examination or apnea testing cannot be completed safely due to the underlying medical condition of the patient

If there is uncertainty about the results of the neurologic examination

If a medication effect may be present

To reduce the inter-examination observation period

Ancillary studies may also be helpful for social reasons allowing family members to better comprehend the diagnosis of brain death

Acceptable tests: angiography, EEG, radionucleotide CBF

Pharmacologic agents that could affect the results of testing should be discontinued and levels determined as clinically indicated. Low to mid therapeutic levels of barbiturates should not preclude the use of EEG testing

Tables detailing EEG and CBF diagnostic yields in brain death

States if ancillary study not consistent with brain death, do not necessarily need to repeat with subsequent evaluation

Acceptable reasons to use ancillary testing

When uncertainty exists about the reliability of parts of the neurologic examination

When the apnea test cannot be performed

Acceptable tests: angiography, EEG, nuclear scan

Discussion of diagnostic yield of various tests in brain death

Death declaration

Time of death not specified

Discusses addressing BD with families, effective communication, supporting families through the process, requests for ongoing organ support

Time of death: time of blood gas with appropriately elevated CO2 or time ancillary test results